XENE compared with DFTX: revenue, margins and what each company keeps, and the suppliers and customers both name

XENEXenon Pharmaceuticals Inc.

Mkt capRevenueRevenue

DFTXDefinium Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

XENEXenon Pharmaceuticals Inc.

DFTXDefinium Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

XENE

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±9.1%▼−1.84%×0.20

May 8 '26±10.3%▲+0.79%×0.08

Q1 FY26±30.3%▼−3.76%×0.13

Nov 4 '25±8.7%▼−4.94%×0.56

DFTX

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±20.9%0.00%×0.00

May 8 '26±9.7%▼−4.96%×0.52

= impliedXENE realized, solidDFTX realized, hatchedOne scale, both sides: full bar = 31%× = |realized| ÷ impliedSource: market data

Q1 FY26

±12.9%

▲+0.93%

×0.07

Jan 12 '26—▲+0.29%—

XENEXenon Pharmaceuticals Inc.

37.69· pre 37.48· delayed

Mkt cap$3.8BRevenue$8MQ1 FY25

DFTXDefinium Therapeutics, Inc.

30.34· pre 30.85· delayed

Pre-marketNov 6 '26delayed

Mkt cap$4.4BRevenue—

Compare

Pre-marketNov 6 '26delayed

XENEXenon Pharmaceuticals Inc.

DFTXDefinium Therapeutics, Inc.

37.69pre 37.48delayed

Price

30.34pre 30.85delayed

$3.8B

Mkt cap

$4.4B

Q1 FY25$8M

Revenue

—

XENE37.69vsDFTX30.34Pre-marketNov 6 '26delayed